ACCC alleges misleading representation over Voltaren pain relief gels

GSK says it's disappointed after the ACCC announced it was taking it and Novartis to court over alleged misleading representations The ACCC announced that it has instituted proceedings in the Federal Court of Australia against GlaxoSmithKline Healthcare Australia Pty Ltd and Novartis Consumer Health Australasia Pty Ltd, alleging they made false or misleading representations in

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Should you recommend NRT to pregnant women?
Next How pollution cancels cardiovascular benefits